Airfluzal Fospiron 500
Salmeterol Xinafoate Micronized · Fluticasone Propionate
Prescription medication · Combination
Korea Sandos Co., Ltd.
MFDS item code 201400922 · Approved 2014.02.28
This product's status changed to Approval withdrawn on 2023.07.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of symptoms of asthma (bronchodilation, inflammation)
This medication is highly effective for asthma patients when used in combination with a bronchodilator and an inhaled corticosteroid. These two drugs respectively relax the muscles of the airways and reduce inflammation, making it easier to breathe. The combination treatment helps alleviate symptoms and prevent asthma attacks. It assists in improving respiratory health and reducing difficulties in daily life. Therefore, the combination therapy of this medication is recommended for asthma treatment.
Adults and children aged 12 and older: Inhalation doses should be administered according to the severity of the disease: Inhale 50 μg of salmeterol + 100 μg of fluticasone propionate twice daily or Inhale 50 μg of salmeterol + 250 μg of fluticasone propionate twice daily or Inhale 50 μg of salmeterol + 500 μg of fluticasone propionate twice daily.
Children aged 4 to 11 years: Inhale 50 μg of salmeterol + 100 μg of fluticasone propionate twice daily.
This medication takes about 10–20 minutes to display bronchodilation effects; thus, it should not be used for acute asthma attacks or severe asthma exacerbations. This drug is not for acute asthma treatment, and quick-relief inhalers should be used for acute symptoms, and patients should always be advised to carry a quick-relief inhaler. It should not be used if there is an allergy to any ingredient in this medication or in patients with cardiac arrhythmia, untreated respiratory infections, or severe bronchiectasis. Caution should be exercised in patients with cardiovascular diseases, diabetes, hyperthyroidism, convulsive disorders, or pulmonary tuberculosis, and the potassium levels in the blood should be monitored carefully. Rarely, various side effects like bronchospasm, palpitations, headache, nausea, muscle pain, skin rash, etc., may occur. If unusual symptoms arise, consult a physician immediately. After inhalation, it is advisable to rinse the mouth and throat with water to prevent side effects like oral candidiasis. If asthma symptoms worsen or if there is an increase in the use of quick-relief inhalers, an evaluation by a physician should be received immediately, and do not suddenly discontinue this medication; taper off according to medical advice. This medication should only be used during pregnancy when the benefits outweigh the risks to the fetus, and if breastfeeding, consultation regarding stopping breastfeeding or discontinuing the medication is needed. Special caution is required for children and elderly patients, especially as safety and efficacy in children under 4 years of age have not been established. When taken with other medications, there may be potential interactions, so caution is advised, especially when taken with cardiac drugs, antibiotics, or antifungals. In the case of overdose, serious symptoms such as cardiac arrhythmia, blood pressure changes, muscle spasms may occur, and immediate medical attention should be sought. This medication is for inhalation only and should not be taken orally. Always adhere to the appropriate dosage and usage as directed by a physician, and regularly monitor the condition during treatment. Additionally, care should be taken for increased infection risks, and attention to preventing chickenpox or measles is essential; seek medical care immediately if any symptoms of infection occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in specially designed containers to prevent exposure to light and air, and it is recommended to be kept in a cool place at or below 25 degrees Celsius. Proper storage helps maintain the effectiveness of the medication and prevents degradation.
A metered-dose inhaler filled with a uniform white powder mounted in a plastic container.
60 doses/1 container
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Salmeterol Xinafoate Micronized · Fluticasone Propionate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Salmeterol Xinafoate Micronized · Fluticasone Propionate
Prescription medication · Combination
Korea Sanofi (Co., Ltd.)
Salmeterol Xinafoate Micronized · Fluticasone Propionate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.